Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
Hosseinipour
M C
MC
University of North Carolina Project, Lilongwe, Malawi. mina_hosseinipour@med.unc.edu
Kumwenda
J J
JJ
Weigel
R
R
Brown
L B
LB
Mzinganjira
D
D
Mhango
B
B
Eron
J J
JJ
Phiri
S
S
van Oosterhout
J J
JJ